Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Ampio Pharmaceuticals, Inc. (AMPE)

-NasdaqCM

5.03 Up 0.03(0.60%) May 17, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 13   13   13   13  
Cost of Revenue -   -   -   -  
Gross Profit 13   13   13   13  
Operating Expenses
Research Development2,787  2,334  2,135  1,552  
Selling General and Administrative1,312  1,436  678  727  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,086) (3,757) (2,801) (2,266)
Income from Continuing Operations
Total Other Income/Expenses Net(122)80  217  (230)
Earnings Before Interest And Taxes(4,208)(3,677)(2,584)(2,496)
Interest Expense -   -   -   -  
Income Before Tax(4,208)(3,677)(2,584)(2,496)
Income Tax Expense -   -   -   -  
Minority Interest30   -   -   -  
Net Income From Continuing Ops(4,179)(3,677)(2,584)(2,496)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,179) (3,677) (2,584) (2,496)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,179) (3,677) (2,584) (2,496)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.